Evaluation of renal function equations to predict amikacin clearance

References

• Delanaye P, Guerber F, Scheen A, et al. Discrepancies between the Cockcroft–Gault and chronic kidney disease epidemiology (CKD-EPI) equations: implications for refining drug dosage adjustment strategies. Clin Pharmacokinet. 2017;56(2):193–205.
   PubMed Web of Science ®Google Scholar
• Tett SE, Kirkpatrick CMJ, Gross AS, et al. Principles and clinical application of assessing alterations in renal elimination pathways. Clin Pharmacokinet. 2003;42(14):1193–1211.
   PubMed Web of Science ®Google Scholar
• Swedish Council on Health Technology Assessment (SBU). Methods to estimate and measure renal function (glomerular filtration rate). Stockholm: SBU report no 214 (in Swedish); 2013.
   Google Scholar
• Roberts GW, Ibsen PM, Schioler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing. 2009;38(6):698–703.
   PubMed Web of Science ®Google Scholar
• Ryzner KL. Evaluation of aminoglycoside clearance using the modification of diet in renal disease equation versus the Cockcroft-Gault equation as a marker of glomerular filtration rate. Ann Pharmacother. 2010;44(6):1030–1037.
   PubMed Web of Science ®Google Scholar
• Charhon N, Neely MN, Bourguignon L, et al. Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients. Antimicrob Agents Chemother. 2012;56(4):1862–1869.
   PubMed Web of Science ®Google Scholar
• Chin P, Florkowski C, Begg E. The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance. Ann Clin Biochem. 2013;50(6):546–557.
   PubMed Web of Science ®Google Scholar
• Dowling TC, Wang ES, Ferrucci L, et al. Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the baltimore longitudinal study on aging: impact on renal drug dosing. Pharmacotherapy. 2013;33(9):912–921.
   PubMed Web of Science ®Google Scholar
• Glatard A, Bourguignon L, Jelliffe RW, et al. Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients. Antimicrob Agents Chemother. 2015;59(6):2986–2994.
   PubMed Web of Science ®Google Scholar
• Hart LA, Anderson GD. Methods of estimating kidney function for drug dosing in special populations. Clin Pharmacokinet. 2018;57(8):943–976.
   PubMed Web of Science ®Google Scholar
• Musso CG, Álvarez-Gregori J, Jauregui J, et al. Glomerular filtration rate equations: a comprehensive review. Int Urol Nephrol. 2016;48(7):1105–1110.
   PubMed Web of Science ®Google Scholar
• Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806.
   PubMed Web of Science ®Google Scholar
• Björk J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. Scand J Clin Lab Invest. 2011;71(3):232–239.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–772.
   PubMed Web of Science ®Google Scholar
• Elinder C-G, Bárány P, Heimbürger O. The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly. Drugs Aging. 2014;31(7):493–499.
   PubMed Web of Science ®Google Scholar
• Schentag JJ, Lasezkay G, Cumbo TJ, et al. Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother. 1978;13(4):649–656.
   PubMed Web of Science ®Google Scholar
• Zaske DE, Cipolle RJ, Rotschafer JC, et al. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob Agents Chemother. 1982;21(3):407–411.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick, Duffull, Begg. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol. 1999;47(6):637–643.
   PubMed Web of Science ®Google Scholar
• Lanao JM, Domínguez-Gil A, Tabernero JM, et al. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function. Int J Clin Pharmacol Biopharm. 1979;17(4):171–175.
   PubMedGoogle Scholar
• Kato H, Hagihara M, Hirai J, et al. Evaluation of amikacin pharmacokinetics and pharmacodynamics for optimal initial dosing regimen. Drugs R D. 2017;17(1):177–187.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry. Q2B. Validation of Analytical Procedures: methodology [Internet]. Rockville (Maryland): Center of Drug Evaluation and Research (CDER) at the Food and Drug Administration; 1996 [cited 2019 Jun 21]. Available from: https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm073384.pdf.
   Google Scholar
• Romano S, de Gatta M, Del MF CV, et al. Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients. Clin Drug Investig. 1998;15(5):435–444.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
   PubMed Web of Science ®Google Scholar
• Winter MA, Guhr KN, Berg GM. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacother. 2012;32(7):604–612.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Zhang Y, Schmid CH. Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol. 2008;21(6):797–807.
   PubMed Web of Science ®Google Scholar
• Beal SL, Sheiner LB, Boeckmann AJ, et al., eds. NONMEM 7.1.0 Users Guides (1989-2009). Ellicott City, MD: Icon Development Solutions; 2009.
   Google Scholar
• R: Software development life cycle. A description of R’s development, testing, release and maintenance processes [Internet] Vienna (Austria): The R Foundation for Statistical Computing; 2018 [cited 2019 Jun 21]. Available from: https://www.r-project.org/doc/R-SDLC.pdf
   Google Scholar
• Guidance for industry pharmacokinetics in patients with impaired renal function — study design, data analysis, and impact on dosing and labeling [Internet]. Silver Spring (Maryland): Center of Drug Evaluation and Research (CDER) at the Food and Drug Administration; 2010 [cited 2019 Jun 21]. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm204959.pdf.
   Google Scholar
• Willems JM, Vlasveld T, Den Elzen WP, et al. Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old. BMC Geriatr. 2013;13:113.
   PubMed Web of Science ®Google Scholar
• Flamant M, Haymann J-P, Vidal-Petiot E, et al. GFR estimation using the cockcroft-gault, MDRD study, and CKD-EPI equations in the elderly. Am J Kidney Dis. 2012;60(5):847–849.
   PubMed Web of Science ®Google Scholar
• Omuse G, Maina D, Mwangi J, et al. Comparison of equations for estimating glomerular filtration rate in screening for chronic kidney disease in asymptomatic black Africans: a cross sectional study. BMC Nephrol. 2017;18(1):369.
   PubMedGoogle Scholar
• Matthews I, Kirkpatrick C, Holford N. Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Br J Clin Pharmacol. 2004;58(1):8–19.
   PubMed Web of Science ®Google Scholar
• Romano S, MMF DG, Calvo MV, et al. Population pharmacokinetics of amikacin in patients with haematological malignancies. J Antimicrob Chemother. 1999;44(2):235–242.
   PubMed Web of Science ®Google Scholar
• De Gatta M, Del MF MSR, Calvo MV, et al. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients. J Pharm Pharmacol. 2009;61(6):759–766.
   PubMed Web of Science ®Google Scholar
• Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52(6):815–824.
   PubMed Web of Science ®Google Scholar